(Q43123377)

14 November 2017

title

Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series (English)

1 reference

14 November 2017

Alessandra Casonato

1

1 reference

14 November 2017

Lisa Gallinaro

2

1 reference

14 November 2017

Maria Grazia Cattini

3

1 reference

14 November 2017

Francesca Sartorello

4

1 reference

14 November 2017

Elena Pontara

5

1 reference

14 November 2017

Roberto Padrini

6

1 reference

14 November 2017

Antonella Bertomoro

7

1 reference

14 November 2017

Viviana Daidone

8

1 reference

14 November 2017

Antonio Pagnan

9

1 reference

14 November 2017

publication date

30 December 2009

1 reference

14 November 2017

published in

Translational Research

1 reference

14 November 2017

volume

155

1 reference

14 November 2017

issue

4

1 reference

14 November 2017

page(s)

200-208

1 reference

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Biochemistry and genetics of von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Cell biology of von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Type 1 von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Von Willebrand disease type 1: a diagnosis in search of a disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854GIn, and the missense mutation Cys2362Phe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.12.003

10.1016/J.TRSL.2009.12.003

7 January 2021

Identifiers

DOI

1 reference

14 November 2017

1 reference